Breaks Categories: Stock Spotlights

TuesdayApr 10, 2018 2:43 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Delivers Comprehensive Suite of Services to the Hemp and Cannabis Markets

As hemp cultivation in America continues to rise, Marijuana Company of America (OTC: MCOA) is providing a variety of hemp-derived CBD products as well as turnkey services for marketers and growers. An article discussing the company reads: “Through wholly owned subsidiary hempSMART™, MCOA is bringing high quality CBD-based products derived from industrial hemp to market through its affiliate marketing program. Its patent-pending product, hempSMART Brain, provides safe and effective support of healthy brain function, while its recently launched HempSMART DROPS is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The company recently debuted its new encapsulate product,…

Continue Reading

TuesdayApr 10, 2018 2:34 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Returns to Roots as Financial Services Business Focusing on Blockchain and Cryptocurrency Technology

Market analysis company ChineseInvestors.com (OTCQB: CIIX) is returning to its roots in financial consulting, corporate brand building and educational services for cryptocurrencies following its planned spin-off of CBD-focused assets. An article discussing the company reads: “ChineseInvestors.com, Inc. (OTCQB: CIIX) will return to its roots as a financial consultant and a specialist in cryptocurrency, especially bitcoin, as it spins off its hemp assets into a private company. In a news release (http://cnw.fm/m7XYb), Paul Dickman, CFO of CIIX, said, “This is a great time to spin off CIIX’s CBD focused assets as we continue to explore new ways to expand its core…

Continue Reading

MondayApr 09, 2018 2:47 pm

CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Reports Record-breaking Sales Revenue in February

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently announced that February marked the company’s highest-ever sales revenue month. The company reported a 90% revenue increase compared to February 2017 (http://cnw.fm/B6Rto). An article discussing the company reads: “In a news release, Nickolas Tabraue, company president, director and COO, noted February to be a pivotal month, giving praise to newly appointed CSO Jill Buzan while appointing Gabriel Aviles as the company’s chief learning officer. “Jill Buzan has brought so much to our company, and with her experience and knowledge Earth Science…

Continue Reading

FridayApr 06, 2018 3:29 pm

CannabisNewsBreaks – EVIO, Inc. (EVIO) Cannabis Testing Services Ensure Safety, Analyze Potency

EVIO (OTCQB: EVIO), a life sciences and cannabis testing company, provides laboratory testing to ensure that consumers receive products that meet stringent standards of healthful quality. An article discussing the company’s services reads: “The company plans to reach a total of 18 laboratories in the United States by the end of the year. In the meantime, clients can bring plant samples into the Oregon-based company’s labs in Colorado or four other states along the East and West Coasts or ask a lab representative to make an on-site visit for random sampling. The lab will visually inspect the plants for signs…

Continue Reading

FridayApr 06, 2018 3:23 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Technology Could Revolutionize Smokeless Tobacco

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) revolutionary DehydraTECH™ technology has proven to be effective in cannabinoid delivery and is now undergoing testing for nicotine. An article discussing the company reads: “Lexaria is now looking to out-license its DehydraTECH to third-party partners in the tobacco industry. These partnerships could pave the way for a healthier smoke-free option for the one billion smokers worldwide. Lexaria is the only company in the world that holds a patent for this oral technology, including the pill. A new U.S. patent award protects this nicotine delivery system, creating a path for what could be the world’s…

Continue Reading

FridayApr 06, 2018 3:09 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Employs Seasoned Executives to Shape Diverse Portfolio

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), along with its subsidiaries, has been strengthening its scientific, legal and accounting teams with experienced leadership additions. An article discussing the company reads: “Together, the team is building a diversified portfolio of companies. Through this portfolio, it is helping to market high quality, medicinal-grade cannabis products with great promise for both human and veterinary use as Canada nears openness to all aspects of marijuana use later this year. Liberty Leaf continues seeking out productive, revenue-generating cannabis ventures in which to invest while simultaneously building its own working capital base. Its North…

Continue Reading

ThursdayApr 05, 2018 10:12 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Continues to Advance Sol-gel Drug Delivery Technology

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) believes that its unique cannabinoid-based, nose-to-brain delivery technology, which employs its Sol-gel platform, is on track to become the first of its kind to be FDA-approved. An article discussing the company’s technology reads: “PreveCeutical believes that its cannabinoid-based nose-to-brain delivery technology, using a Sol-gel platform, will be the first to gain Food and Drug Administration approval. Its water soluable, alcohol free nasal formulation which will be developed for use by adults, children and people of certain beliefs. … PreveCeutical’s groundbreaking Sol-gel delivery system displays significant benefits over other contemporary…

Continue Reading

WednesdayApr 04, 2018 3:23 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Builds Diverse Portfolio in Flourishing Market Space

Marijuana Company of America (OTC: MCOA) continues to employ its diversified business plan, creating a broad range of opportunities within the flourishing cannabis market. An article discussing the company reads: “In spite of all of the short-term political gyrations, the cannabis and hemp markets continue to bloom. The demand for cannabidiol (CBD) products remains persistent, and there are many attractive opportunities in the sector. Marijuana Company of America, Inc. (OTC: MCOA) is in position to thrive in spite of any short-term contortions in the cannabis and hemp markets. The company’s low-risk, high-return profile results from its focus on industrial hemp-based…

Continue Reading

WednesdayApr 04, 2018 3:14 pm

CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Subsidiary Demonstrates Innovation in the Pharmaceutical Industry

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, recently said that its subsidiary, Canna Inno Laboratories Inc., received a grant from the Government of Québec for innovation in the pharmaceutical industry. An article discussing the company reads: “Earth Science Tech formed Canna Inno Laboratories, Inc. in 2017. Strategically headquartered in Montreal, Quebec, it allows Earth Science Tech access to Canadian government and private grants offered to companies for innovation in the pharmaceutical industry. The awarded grant will support the pre-launch process of Earth Science’s three CBD-based products. These nutraceutical products…

Continue Reading

MondayApr 02, 2018 2:31 pm

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) To Capitalize on Growing Demand for CBD-based Health Products

Market analysis company ChineseInvestors.com (OTCQB: CIIX) recently announced its plan to spinoff all hemp-related assets into a single private company. CBD Biotechnology Co. Ltd., ChineseHempOil.com, Inc. and Hemp Logic Inc. will comprise the new company. An article discussing the company’s plan reads: “The subsidiaries are well positioned to achieve significant growth. This spinoff is part of the groundwork to capitalize on the growing demand for CBD-based nutrition and health products in the U.S. and China. In January, these subsidiaries made a combined $100,000. The progress of the newly formed company will be overseen by CIIX, but the spinoff of CBD-focused…

Continue Reading